•The Federal Reserve Board announced an enforcement action against American Express Company for failing to sufficiently detect and report suspicious activity related to money laundering.
•The PhRMA lobbying group filed a lawsuit against the federal government challenging the most-favored-nation policy aimed at reducing Medicare drug prices.
•The lawsuit alleges the program exceeds CMS authority and illegally imposes foreign price controls on domestic pharmaceuticals.
•VSBLTY announced that the British Columbia Securities Commission has revoked the full, final, and comprehensive cease trade order issued against the company.
•Trading of the company's common shares has resumed on the Canadian Securities Exchange (CSE).
